ImpediMed Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	12.72	10.32	11.34	10.5	8.35
Other Revenue	-	-	-	0.07	0.06
Revenue	12.72	10.32	11.34	10.57	8.41
Revenue Growth (YoY)	23.31%	-9.04%	7.36%	25.65%	46.47%
Cost of Revenue	1.75	1.31	1.55	1.71	1.55
Gross Profit	10.98	9.01	9.8	8.86	6.86
Selling, General & Admin	26.48	26.19	25.29	23.67	24.55
Research & Development	0.15	0.22	0.6	0.68	1.46
Other Operating Expenses	2.79	3.41	4.31	3.2	2.12
Operating Expenses	33.98	32.08	32.66	30.32	29.82
Operating Income	-23.01	-23.07	-22.87	-21.47	-22.97
Interest Expense	-1.16	-0.09	-0.03	-0.03	-0.05
Interest & Investment Income	0.96	1.56	0.8	0.05	0.02
Other Non Operating Income (Expenses)	-	-	1.61	1.62	1.79
EBT Excluding Unusual Items	-23.21	-21.6	-20.49	-19.83	-21.21
Asset Writedown	-	-	-	-	-0.05
Other Unusual Items	-	1.85	-	-	0.59
Pretax Income	-23.21	-19.76	-20.49	-19.83	-20.67
Income Tax Expense	0.03	0.03	0.03	0.05	0.04
Earnings From Continuing Operations	-23.24	-19.79	-20.52	-19.87	-20.71
Net Income	-23.24	-19.79	-20.52	-19.87	-20.71
Net Income to Common	-23.24	-19.79	-20.52	-19.87	-20.71
Shares Outstanding (Basic)	2,019	2,022	1,800	1,679	1,202
Shares Outstanding (Diluted)	2,019	2,022	1,800	1,679	1,202
Shares Change (YoY)	-0.13%	12.30%	7.23%	39.64%	102.01%
EPS (Basic)	-0.01	-0.01	-0.01	-0.01	-0.02
EPS (Diluted)	-0.01	-0.01	-0.01	-0.01	-0.02
Free Cash Flow	-14.71	-17.87	-18.44	-15.72	-13.32
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.01	-0.01
Gross Margin	86.25%	87.27%	86.37%	83.83%	81.54%
Operating Margin	-180.82%	-223.57%	-201.56%	-203.16%	-273.12%
Profit Margin	-182.62%	-191.78%	-180.90%	-188.09%	-246.24%
Free Cash Flow Margin	-115.57%	-173.18%	-162.56%	-148.82%	-158.45%
EBITDA	-22.78	-22.8	-22.61	-20.23	-22.61
EBITDA Margin	-178.99%	-220.97%	-199.32%	-191.46%	-268.91%
D&A For EBITDA	0.23	0.27	0.25	1.24	0.35
EBIT	-23.01	-23.07	-22.87	-21.47	-22.97
EBIT Margin	-180.82%	-223.57%	-201.56%	-203.16%	-273.12%
Revenue as Reported	-	-	-	10.56	8.41
Advertising Expenses	0.8	0.52	0.46	0.67	0.45

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.